2-mercaptomethyl-3-guanidinoethylthiopropionic acid has been researched along with fibrin in 1 studies
| Studies (2-mercaptomethyl-3-guanidinoethylthiopropionic acid) | Trials (2-mercaptomethyl-3-guanidinoethylthiopropionic acid) | Recent Studies (post-2010) (2-mercaptomethyl-3-guanidinoethylthiopropionic acid) | Studies (fibrin) | Trials (fibrin) | Recent Studies (post-2010) (fibrin) |
|---|---|---|---|---|---|
| 44 | 0 | 2 | 15,994 | 328 | 3,808 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, H; Muto, Y; Sato, E; Suzuki, K | 1 |
1 other study(ies) available for 2-mercaptomethyl-3-guanidinoethylthiopropionic acid and fibrin
| Article | Year |
|---|---|
Carboxypeptidase B inhibitors reduce tissue factor-induced renal microthrombi in rats.
Topics: 3-Mercaptopropionic Acid; Animals; Carboxypeptidase B; Carboxypeptidases; Dose-Response Relationship, Drug; Fibrin; Fibrinolysis; Kidney; Kidney Glomerulus; Male; Protease Inhibitors; Rats; Rats, Wistar; Thromboplastin; Thrombosis | 2003 |